Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$6.72M
21 trades · 6 insiders
Net · 90d
$-6.72M
Insiders on file
17
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| MILNE GEORGE M JR | Director | 15 | $720.0K | $1.95M | 2026-10-05 |
| Mazzariello Gina | Chief Legal Officer | 38 | $0 | $2.18M | 2026-09-10 |
| Cohen Joshua B | Co-Chief Executive Officer, Director | 50 | $0 | $8.80M | 2026-09-10 |
| Klee Justin B. | Co-Chief Executive Officer, Director | 48 | $0 | $8.80M | 2026-09-10 |
| Bedrosian Camille L | Chief Medical Officer | 20 | $0 | $1.12M | 2026-09-10 |
| FRATES JAMES M | Chief Financial Officer | 50 | $101.2K | $4.22M | 2026-09-10 |
| Firestone Karen | Director | 18 | $350.6K | $0 | 2026-08-31 |
| Zeiher Bernhardt G | Director | 5 | $37.0K | $0 | 2026-06-04 |
| FONTEYNE PAUL R. | Director | 7 | $75.0K | $0 | 2026-06-04 |
| Quimi Daphne | Director | 8 | $9.4K | $0 | 2026-06-04 |
| Yeramian Patrick D | Chief Medical Officer | 30 | $0 | $5.46M | 2024-01-09 |
| Olinger Margaret | Chief Commercial Officer | 12 | $130.0K | $87.2K | 2023-12-27 |
| Morningside Venture Investments Ltd | 10% Owner | 24 | $5.00M | $22.54M | 2023-08-15 |
| Viking Global Opportunities Illiquid Investments Sub-Master LP | 10% Owner | 19 | $43.70M | $41.72M | 2022-11-11 |
| ALS Invest 1 B.V. | 10% Owner | 8 | $0 | $1.25M | 2022-07-06 |
| Cheng Isaac | Director | 11 | $125.0K | $0 | 2022-06-09 |
| MVIL, LLC | 10% Owner | 6 | $5.00M | $0 | 2022-01-11 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| MILNE GEORGE M JR | Director | S Sale | 2026-10-05 | 2026-10-07 | 30,000 | $27.70 | $830.9K | 782,881 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | S Sale | 2026-09-10 | 2026-09-14 | 29,025 | $32.13 | $932.6K | 3,614,495 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | S Sale | 2026-09-10 | 2026-09-14 | 1,439 | $33.16 | $47.7K | 3,613,056 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | S Sale | 2026-09-10 | 2026-09-14 | 29,545 | $32.16 | $950.2K | 3,614,042 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | S Sale | 2026-09-10 | 2026-09-14 | 919 | $33.15 | $30.5K | 3,613,123 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | S Sale | 2026-09-10 | 2026-09-14 | 11 | $33.34 | $367 | 190,838 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | S Sale | 2026-09-10 | 2026-09-14 | 9,525 | $32.46 | $309.2K | 190,849 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | S Sale | 2026-09-10 | 2026-09-14 | 1,042 | $33.23 | $34.6K | 233,625 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | S Sale | 2026-09-10 | 2026-09-14 | 9,768 | $32.27 | $315.2K | 234,667 | SEC↗ |
| Bedrosian Camille L | Chief Medical Officer | S Sale | 2026-09-10 | 2026-09-14 | 2,081 | $33.09 | $68.9K | 278,064 | SEC↗ |
| Bedrosian Camille L | Chief Medical Officer | S Sale | 2026-09-10 | 2026-09-14 | 7,947 | $32.21 | $256.0K | 280,145 | SEC↗ |
| Bedrosian Camille L | Chief Medical Officer | S Sale | 2026-09-10 | 2026-09-14 | 2,081 | $33.09 | $68.9K | 278,064 | SEC↗ |
| Bedrosian Camille L | Chief Medical Officer | S Sale | 2026-09-10 | 2026-09-14 | 7,947 | $32.21 | $256.0K | 280,145 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | S Sale | 2026-09-10 | 2026-09-14 | 1,042 | $33.23 | $34.6K | 233,625 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | S Sale | 2026-09-10 | 2026-09-14 | 9,768 | $32.27 | $315.2K | 234,667 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | S Sale | 2026-09-10 | 2026-09-14 | 11 | $33.34 | $367 | 190,838 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | S Sale | 2026-09-10 | 2026-09-14 | 9,525 | $32.46 | $309.1K | 190,849 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer, | S Sale | 2026-09-10 | 2026-09-14 | 919 | $33.15 | $30.5K | 3,613,123 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer, | S Sale | 2026-09-10 | 2026-09-14 | 29,545 | $32.16 | $950.0K | 3,614,042 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer, | S Sale | 2026-09-10 | 2026-09-14 | 1,439 | $33.16 | $47.7K | 3,613,056 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer, | S Sale | 2026-09-10 | 2026-09-14 | 29,025 | $32.13 | $932.6K | 3,614,495 | SEC↗ |
| Firestone Karen | Director | M Exercise deriv | 2026-08-31 | 2026-09-02 | 25,000 | — | $0 | 0 | SEC↗ |
| Firestone Karen | Director | M Exercise deriv | 2026-08-31 | 2026-09-02 | 25,000 | — | $0 | 0 | SEC↗ |
| Firestone Karen | Director | M Exercise | 2026-08-31 | 2026-09-02 | 25,000 | $5.05 | $126.3K | 116,900 | SEC↗ |
| Firestone Karen | Director | M Exercise | 2026-08-31 | 2026-09-02 | 25,000 | $1.76 | $44.0K | 91,900 | SEC↗ |
| Firestone Karen | Director | M Exercise deriv | 2026-08-31 | 2026-09-02 | 25,000 | — | $0 | 0 | SEC↗ |
| Firestone Karen | Director | M Exercise deriv | 2026-08-31 | 2026-09-02 | 25,000 | — | $0 | 0 | SEC↗ |
| Firestone Karen | Director | M Exercise | 2026-08-31 | 2026-09-02 | 25,000 | $5.05 | $126.3K | 116,900 | SEC↗ |
| Firestone Karen | Director | M Exercise | 2026-08-31 | 2026-09-02 | 25,000 | $1.76 | $44.0K | 91,900 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | A Award | 2026-08-18 | 2026-08-20 | 60,039 | — | $0 | 3,643,587 | SEC↗ |
| Bedrosian Camille L | Chief Medical Officer | A Award | 2026-08-18 | 2026-08-20 | 22,807 | — | $0 | 288,092 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | A Award | 2026-08-18 | 2026-08-20 | 21,284 | — | $0 | 200,374 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | A Award | 2026-08-18 | 2026-08-20 | 60,039 | — | $0 | 3,643,520 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | A Award | 2026-08-18 | 2026-08-20 | 22,807 | — | $0 | 244,435 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | A Award | 2026-08-18 | 2026-08-20 | 22,807 | — | $0 | 244,435 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer, | A Award | 2026-08-18 | 2026-08-20 | 60,039 | — | $0 | 3,643,520 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | A Award | 2026-08-18 | 2026-08-20 | 21,284 | — | $0 | 200,374 | SEC↗ |
| Bedrosian Camille L | Chief Medical Officer | A Award | 2026-08-18 | 2026-08-20 | 22,807 | — | $0 | 288,092 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer, | A Award | 2026-08-18 | 2026-08-20 | 60,039 | — | $0 | 3,643,587 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | S Sale | 2026-07-10 | 2026-07-13 | 15,000 | $17.61 | $264.1K | 179,090 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | S Sale | 2026-07-09 | 2026-07-13 | 15,000 | $18.32 | $274.8K | 194,090 | SEC↗ |
| FONTEYNE PAUL R. | Director | A Award deriv | 2026-06-04 | 2026-06-08 | 24,372 | — | $0 | 24,372 | SEC↗ |
| MILNE GEORGE M JR | Director | A Award deriv | 2026-06-04 | 2026-06-08 | 24,372 | — | $0 | 24,372 | SEC↗ |
| Quimi Daphne | Director | A Award deriv | 2026-06-04 | 2026-06-08 | 24,372 | — | $0 | 24,372 | SEC↗ |
| Firestone Karen | Director | A Award deriv | 2026-06-04 | 2026-06-08 | 24,372 | — | $0 | 24,372 | SEC↗ |
| Zeiher Bernhardt G | Director | A Award deriv | 2026-06-04 | 2026-06-08 | 24,372 | — | $0 | 24,372 | SEC↗ |
| Firestone Karen | Director | P Buy | 2026-05-21 | 2026-05-26 | 3,800 | $13.51 | $51.3K | 66,900 | SEC↗ |
| Bedrosian Camille L | Chief Medical Officer | A Award deriv | 2026-03-05 | 2026-03-09 | 143,985 | — | $0 | 143,985 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | A Award deriv | 2026-03-05 | 2026-03-09 | 373,295 | — | $0 | 373,295 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | A Award deriv | 2026-03-05 | 2026-03-09 | 143,985 | — | $0 | 143,985 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | A Award deriv | 2026-03-05 | 2026-03-09 | 111,990 | — | $0 | 111,990 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | A Award deriv | 2026-03-05 | 2026-03-09 | 373,295 | — | $0 | 373,295 | SEC↗ |
| Bedrosian Camille L | Chief Medical Officer | A Award | 2026-03-05 | 2026-03-09 | 95,990 | — | $0 | 265,285 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | A Award | 2026-03-05 | 2026-03-09 | 248,865 | — | $0 | 3,583,481 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | A Award | 2026-03-05 | 2026-03-09 | 95,990 | — | $0 | 261,628 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | A Award | 2026-03-05 | 2026-03-09 | 74,660 | — | $0 | 209,090 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | A Award | 2026-03-05 | 2026-03-09 | 248,865 | — | $0 | 3,583,548 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | S Sale | 2026-03-02 | 2026-03-04 | 6,844 | $14.52 | $99.4K | 134,430 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | S Sale | 2026-03-02 | 2026-03-04 | 7,909 | $14.52 | $114.8K | 165,638 | SEC↗ |
| Bedrosian Camille L | Chief Medical Officer | S Sale | 2026-03-02 | 2026-03-04 | 6,461 | $14.58 | $94.2K | 169,295 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | S Sale | 2026-03-02 | 2026-03-04 | 29,282 | $14.48 | $424.0K | 3,334,683 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | S Sale | 2026-03-02 | 2026-03-04 | 29,282 | $14.47 | $423.7K | 3,334,616 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | S Sale | 2026-02-23 | 2026-02-25 | 3,419 | $14.14 | $48.3K | 141,274 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | S Sale | 2026-02-02 | 2026-02-04 | 15,500 | $14.69 | $227.7K | 3,363,898 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | S Sale | 2026-02-02 | 2026-02-04 | 3,448 | $14.65 | $50.5K | 144,693 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | S Sale | 2026-02-02 | 2026-02-04 | 15,500 | $14.68 | $227.5K | 3,363,965 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | S Sale | 2026-02-02 | 2026-02-04 | 3,557 | $14.65 | $52.1K | 173,547 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | M Exercise deriv | 2026-01-16 | 2026-01-20 | 2,847 | — | $0 | 0 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | M Exercise deriv | 2026-01-16 | 2026-01-20 | 2,818 | — | $0 | 0 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | S Sale | 2026-01-16 | 2026-01-20 | 1,995 | $13.89 | $27.7K | 3,379,398 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | M Exercise | 2026-01-16 | 2026-01-20 | 2,847 | $7.57 | $21.6K | 3,381,393 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | S Sale | 2026-01-16 | 2026-01-20 | 1,974 | $13.83 | $27.3K | 3,379,465 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | M Exercise | 2026-01-16 | 2026-01-20 | 2,818 | $7.57 | $21.3K | 3,381,439 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | M Exercise deriv | 2026-01-15 | 2026-01-20 | 197,153 | — | $0 | 2,847 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | M Exercise deriv | 2026-01-15 | 2026-01-20 | 197,182 | — | $0 | 2,818 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | S Sale | 2026-01-15 | 2026-01-20 | 136,193 | $13.58 | $1.85M | 3,378,546 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | M Exercise | 2026-01-15 | 2026-01-20 | 197,153 | $7.57 | $1.49M | 3,514,739 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | S Sale | 2026-01-15 | 2026-01-20 | 136,193 | $13.59 | $1.85M | 3,378,621 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | M Exercise | 2026-01-15 | 2026-01-20 | 197,182 | $7.57 | $1.49M | 3,514,814 | SEC↗ |
| MILNE GEORGE M JR | Director | G Gift | 2026-01-12 | 2026-01-14 | 17,780 | — | $0 | 812,881 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | S Sale | 2026-01-06 | 2026-01-08 | 7,715 | $11.09 | $85.6K | 3,317,586 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | S Sale | 2026-01-06 | 2026-01-08 | 7,715 | $11.09 | $85.6K | 3,317,632 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | S Sale | 2026-01-06 | 2026-01-08 | 3,326 | $11.11 | $37.0K | 177,104 | SEC↗ |
| Firestone Karen | Director | P Buy | 2025-12-23 | 2025-12-23 | 8,100 | $12.45 | $100.8K | 63,100 | SEC↗ |
| Bedrosian Camille L | Chief Medical Officer | S Sale | 2025-12-01 | 2025-12-03 | 6,580 | $14.35 | $94.4K | 175,756 | SEC↗ |
| Bedrosian Camille L | Chief Medical Officer | S Sale | 2025-09-30 | 2025-10-02 | 12,039 | $14.58 | $175.5K | 182,336 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | S Sale | 2025-09-30 | 2025-10-02 | 200 | $15.00 | $3.0K | 3,325,347 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | S Sale | 2025-09-30 | 2025-10-02 | 29,733 | $14.34 | $426.4K | 3,325,547 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | S Sale | 2025-09-30 | 2025-10-02 | 10,558 | $14.65 | $154.7K | 280,430 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | S Sale | 2025-09-30 | 2025-10-02 | 8,828 | $14.58 | $128.7K | 148,141 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | S Sale | 2025-09-30 | 2025-10-02 | 200 | $15.01 | $3.0K | 3,325,301 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | S Sale | 2025-09-30 | 2025-10-02 | 29,775 | $14.37 | $427.9K | 3,325,501 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | S Sale | 2025-08-13 | 2025-08-14 | 15,000 | $8.34 | $125.1K | 156,969 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | S Sale | 2025-08-12 | 2025-08-14 | 15,000 | $8.07 | $121.0K | 171,969 | SEC↗ |
| Zeiher Bernhardt G | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MILNE GEORGE M JR | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Quimi Daphne | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Firestone Karen | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 25,000 | — | $0 | 25,000 | SEC↗ |
| FONTEYNE PAUL R. | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | G Gift | 2025-05-22 | 2025-05-27 | 1,000 | — | $0 | 186,969 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | S Sale | 2025-03-31 | 2025-04-02 | 21,490 | $3.46 | $74.4K | 3,355,276 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | S Sale | 2025-03-31 | 2025-04-02 | 21,490 | $3.47 | $74.6K | 3,355,280 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | S Sale | 2025-03-31 | 2025-04-02 | 9,192 | $3.48 | $32.0K | 187,969 | SEC↗ |
| Bedrosian Camille L | Chief Medical Officer | S Sale | 2025-03-31 | 2025-04-02 | 12,425 | $3.47 | $43.1K | 194,375 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | S Sale | 2025-03-31 | 2025-04-02 | 10,896 | $3.47 | $37.8K | 290,988 | SEC↗ |
| Zeiher Bernhardt G | Director | P Buy | 2025-03-20 | 2025-03-24 | 10,000 | $3.70 | $37.0K | 10,000 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | A Award deriv | 2025-03-06 | 2025-03-10 | 102,630 | — | $0 | 102,630 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | A Award deriv | 2025-03-06 | 2025-03-10 | 270,177 | — | $0 | 270,177 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | A Award deriv | 2025-03-06 | 2025-03-10 | 270,177 | — | $0 | 270,177 | SEC↗ |
| Bedrosian Camille L | Chief Medical Officer | A Award deriv | 2025-03-06 | 2025-03-10 | 102,630 | — | $0 | 102,630 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | A Award deriv | 2025-03-06 | 2025-03-10 | 95,777 | — | $0 | 95,777 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | A Award | 2025-03-06 | 2025-03-10 | 68,420 | — | $0 | 301,884 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | A Award | 2025-03-06 | 2025-03-10 | 180,118 | — | $0 | 3,376,770 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | A Award | 2025-03-06 | 2025-03-10 | 180,118 | — | $0 | 3,376,766 | SEC↗ |
| Bedrosian Camille L | Chief Medical Officer | A Award | 2025-03-06 | 2025-03-10 | 68,420 | — | $0 | 206,800 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | A Award | 2025-03-06 | 2025-03-10 | 63,851 | — | $0 | 197,161 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | S Sale | 2025-03-03 | 2025-03-05 | 1,611 | $3.12 | $5.0K | 133,310 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | S Sale | 2025-03-03 | 2025-03-05 | 4,595 | $3.17 | $14.6K | 3,196,652 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | S Sale | 2025-03-03 | 2025-03-05 | 4,595 | $3.15 | $14.5K | 3,196,648 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | S Sale | 2025-02-24 | 2025-02-26 | 4,169 | $3.15 | $13.1K | 134,921 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | M Exercise deriv | 2025-02-05 | 2025-02-06 | 36,310 | — | $0 | 0 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | M Exercise | 2025-02-05 | 2025-02-06 | 36,310 | $1.57 | $57.0K | 3,201,243 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | S Sale | 2025-02-03 | 2025-02-05 | 11,855 | $3.47 | $41.1K | 3,164,933 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | S Sale | 2025-02-03 | 2025-02-05 | 11,851 | $3.47 | $41.1K | 3,201,247 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | S Sale | 2025-02-03 | 2025-02-05 | 3,678 | $3.49 | $12.8K | 139,090 | SEC↗ |
| MILNE GEORGE M JR | Director | G Gift | 2025-01-24 | 2025-01-28 | 27,910 | — | $0 | 830,661 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | S Sale | 2025-01-06 | 2025-01-08 | 7,471 | $4.05 | $30.3K | 3,213,098 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | S Sale | 2025-01-06 | 2025-01-08 | 7,471 | $4.04 | $30.2K | 3,176,788 | SEC↗ |
| Bedrosian Camille L | Chief Medical Officer | S Sale | 2024-12-02 | 2024-12-03 | 5,421 | $5.54 | $30.0K | 138,380 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | M Exercise deriv | 2024-11-04 | 2024-11-06 | 63,690 | — | $0 | 36,310 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | M Exercise | 2024-11-04 | 2024-11-06 | 63,690 | $1.57 | $100.0K | 3,184,259 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | S Sale | 2024-09-30 | 2024-10-02 | 8,709 | $3.20 | $27.9K | 142,768 | SEC↗ |
| Bedrosian Camille L | Chief Medical Officer | S Sale | 2024-09-30 | 2024-10-02 | 11,442 | $3.20 | $36.6K | 143,801 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | S Sale | 2024-09-30 | 2024-10-02 | 18,589 | $3.20 | $59.5K | 3,220,569 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | S Sale | 2024-09-30 | 2024-10-02 | 18,589 | $3.20 | $59.5K | 3,120,569 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | M Exercise deriv | 2024-09-23 | 2024-09-25 | 1,857 | — | $0 | 0 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | M Exercise | 2024-09-23 | 2024-09-25 | 1,857 | $1.57 | $2.9K | 3,239,158 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | M Exercise deriv | 2024-09-12 | 2024-09-16 | 34,449 | — | $0 | 1,857 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | P Buy | 2024-09-12 | 2024-09-16 | 40,000 | $2.53 | $101.2K | 233,464 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | M Exercise | 2024-09-12 | 2024-09-16 | 34,449 | $1.57 | $54.1K | 3,237,301 | SEC↗ |
| Firestone Karen | Director | P Buy | 2024-09-05 | 2024-09-09 | 50,000 | $2.13 | $106.5K | 55,000 | SEC↗ |
| MILNE GEORGE M JR | Director | P Buy | 2024-09-03 | 2024-09-05 | 100,000 | $2.20 | $220.0K | 858,571 | SEC↗ |
| Quimi Daphne | Director | A Award deriv | 2024-06-06 | 2024-06-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MILNE GEORGE M JR | Director | A Award deriv | 2024-06-06 | 2024-06-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Zeiher Bernhardt G | Director | A Award deriv | 2024-06-06 | 2024-06-07 | 5,753 | — | $0 | 5,753 | SEC↗ |
| Firestone Karen | Director | A Award deriv | 2024-06-06 | 2024-06-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| FONTEYNE PAUL R. | Director | A Award deriv | 2024-06-06 | 2024-06-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | S Sale | 2024-05-15 | 2024-05-16 | 10,455 | $1.88 | $19.7K | 151,477 | SEC↗ |
| Quimi Daphne | Director | P Buy | 2024-05-15 | 2024-05-16 | 2,250 | $1.89 | $4.3K | 5,000 | SEC↗ |
| Quimi Daphne | Director | P Buy | 2024-05-14 | 2024-05-16 | 2,750 | $1.89 | $5.2K | 2,750 | SEC↗ |
| Bedrosian Camille L | Chief Medical Officer | A Award deriv | 2024-04-16 | 2024-04-18 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | A Award deriv | 2024-04-16 | 2024-04-18 | 380,000 | — | $0 | 380,000 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | A Award deriv | 2024-04-16 | 2024-04-18 | 110,000 | — | $0 | 110,000 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | A Award deriv | 2024-04-16 | 2024-04-18 | 380,000 | — | $0 | 380,000 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | A Award deriv | 2024-04-16 | 2024-04-18 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Bedrosian Camille L | Chief Medical Officer | A Award | 2024-04-16 | 2024-04-18 | 96,910 | — | $0 | 155,243 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | A Award | 2024-04-16 | 2024-04-18 | 179,850 | — | $0 | 3,139,158 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | A Award | 2024-04-16 | 2024-04-18 | 80,560 | — | $0 | 161,932 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | A Award | 2024-04-16 | 2024-04-18 | 179,850 | — | $0 | 3,202,852 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | A Award | 2024-04-16 | 2024-04-18 | 91,180 | — | $0 | 225,964 | SEC↗ |
| Zeiher Bernhardt G | Director | A Award deriv | 2024-03-14 | 2024-03-15 | 50,000 | — | $0 | 50,000 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | S Sale | 2024-03-05 | 2024-03-07 | 1,792 | $18.73 | $33.6K | 134,784 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | S Sale | 2024-03-05 | 2024-03-07 | 1,540 | $18.73 | $28.8K | 81,372 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | S Sale | 2024-03-05 | 2024-03-07 | 4,135 | $18.73 | $77.4K | 2,959,308 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | S Sale | 2024-03-05 | 2024-03-07 | 4,135 | $18.73 | $77.4K | 3,023,002 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | A Award deriv | 2024-02-26 | 2024-02-28 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | A Award deriv | 2024-02-26 | 2024-02-28 | 190,000 | — | $0 | 190,000 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | A Award deriv | 2024-02-26 | 2024-02-28 | 190,000 | — | $0 | 190,000 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | A Award deriv | 2024-02-26 | 2024-02-28 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | A Award | 2024-02-26 | 2024-02-28 | 36,667 | — | $0 | 82,912 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | A Award | 2024-02-26 | 2024-02-28 | 126,667 | — | $0 | 2,963,443 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | A Award | 2024-02-26 | 2024-02-28 | 126,667 | — | $0 | 3,027,137 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | A Award | 2024-02-26 | 2024-02-28 | 40,000 | — | $0 | 152,035 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | S Sale | 2024-02-23 | 2024-02-27 | 2,838 | $18.76 | $53.2K | 46,245 | SEC↗ |
| MILNE GEORGE M JR | Director | G Gift | 2024-01-25 | 2024-01-29 | 9,100 | — | $0 | 758,571 | SEC↗ |
| MILNE GEORGE M JR | Director | G Gift | 2024-01-16 | 2024-01-18 | 94,350 | — | $0 | 767,671 | SEC↗ |
| Yeramian Patrick D | Chief Medical Officer | S Sale | 2024-01-09 | 2024-01-11 | 2,812 | $16.33 | $45.9K | 205,605 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | S Sale | 2024-01-09 | 2024-01-11 | 5,841 | $16.33 | $95.4K | 2,900,470 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | S Sale | 2024-01-09 | 2024-01-11 | 2,716 | $16.33 | $44.4K | 112,035 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | S Sale | 2024-01-09 | 2024-01-11 | 5,841 | $16.33 | $95.4K | 2,836,776 | SEC↗ |
| Olinger Margaret | Chief Commercial Officer | M Exercise deriv | 2023-12-27 | 2023-12-29 | 25,000 | — | $0 | 44,577 | SEC↗ |
| Olinger Margaret | Chief Commercial Officer | M Exercise | 2023-12-27 | 2023-12-29 | 25,000 | $0.37 | $9.3K | 276,108 | SEC↗ |
| Firestone Karen | Director | P Buy | 2023-12-15 | 2023-12-19 | 4,000 | $14.97 | $59.9K | 5,000 | SEC↗ |
| Bedrosian Camille L | Chief Medical Officer | A Award deriv | 2023-11-27 | 2023-11-29 | 162,500 | — | $0 | 162,500 | SEC↗ |
| Bedrosian Camille L | Chief Medical Officer | A Award | 2023-11-27 | 2023-11-29 | 58,333 | — | $0 | 58,333 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | M Exercise deriv | 2023-11-16 | 2023-11-20 | 63,694 | — | $0 | 36,306 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | M Exercise | 2023-11-16 | 2023-11-20 | 63,694 | $1.57 | $100.0K | 2,906,311 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | G Gift | 2023-10-31 | 2023-11-02 | 11,072 | — | $0 | 11,072 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | M Exercise deriv | 2023-08-23 | 2024-09-05 | 18,165 | — | $0 | 363,835 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | M Exercise | 2023-08-23 | 2024-09-05 | 18,165 | $6.88 | $125.0K | 73,841 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | M Exercise deriv | 2023-08-23 | 2023-08-24 | 18,165 | — | $0 | 363,835 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | M Exercise | 2023-08-23 | 2023-08-24 | 18,165 | $6.88 | $125.0K | 106,341 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | S Sale | 2023-08-15 | 2023-08-17 | 6,164 | $20.88 | $128.7K | 49,083 | SEC↗ |
| Morningside Venture Investment | 10% Owner | G Gift | 2023-08-15 | 2023-08-17 | 2,000,000 | — | $0 | 4,997,302 | SEC↗ |
| Olinger Margaret | Chief Commercial Officer | M Exercise deriv | 2023-07-12 | 2023-07-14 | 20,000 | — | $0 | 69,577 | SEC↗ |
| Olinger Margaret | Chief Commercial Officer | M Exercise | 2023-07-12 | 2023-07-14 | 20,000 | $0.37 | $7.4K | 251,108 | SEC↗ |
| FONTEYNE PAUL R. | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 16,985 | — | $0 | 16,985 | SEC↗ |
| Quimi Daphne | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 16,985 | — | $0 | 16,985 | SEC↗ |
| MILNE GEORGE M JR | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 16,985 | — | $0 | 16,985 | SEC↗ |
| Firestone Karen | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 3,908 | — | $0 | 3,908 | SEC↗ |
| Olinger Margaret | Chief Commercial Officer | G Gift | 2023-05-22 | 2023-05-24 | 1,580 | — | $0 | 231,108 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | G Gift | 2023-05-17 | 2023-05-19 | 500 | — | $0 | 55,247 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | M Exercise deriv | 2023-05-16 | 2023-05-18 | 32,500 | — | $0 | 382,000 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | S Sale | 2023-05-16 | 2023-05-18 | 500 | $27.60 | $13.8K | 55,676 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | S Sale | 2023-05-16 | 2023-05-18 | 32,000 | $26.93 | $861.8K | 56,176 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | M Exercise | 2023-05-16 | 2023-05-18 | 32,500 | $6.88 | $223.6K | 88,176 | SEC↗ |
| Yeramian Patrick D | Chief Medical Officer | M Exercise deriv | 2023-05-15 | 2023-05-17 | 2,201 | — | $0 | 15,404 | SEC↗ |
| Yeramian Patrick D | Chief Medical Officer | M Exercise deriv | 2023-05-15 | 2023-05-17 | 9,764 | — | $0 | 33,770 | SEC↗ |
| Yeramian Patrick D | Chief Medical Officer | M Exercise | 2023-05-15 | 2023-05-17 | 9,764 | $6.88 | $67.2K | 220,382 | SEC↗ |
| Yeramian Patrick D | Chief Medical Officer | S Sale | 2023-05-15 | 2023-05-17 | 11,965 | $29.03 | $347.3K | 208,417 | SEC↗ |
| Yeramian Patrick D | Chief Medical Officer | M Exercise | 2023-05-15 | 2023-05-17 | 2,201 | $0.37 | $814 | 210,618 | SEC↗ |
| Yeramian Patrick D | Chief Medical Officer | M Exercise deriv | 2023-04-17 | 2023-04-19 | 44,861 | — | $0 | 17,605 | SEC↗ |
| Yeramian Patrick D | Chief Medical Officer | M Exercise deriv | 2023-04-17 | 2023-04-19 | 4,718 | — | $0 | 43,534 | SEC↗ |
| Yeramian Patrick D | Chief Medical Officer | M Exercise | 2023-04-17 | 2023-04-19 | 4,718 | $6.88 | $32.5K | 257,996 | SEC↗ |
| Yeramian Patrick D | Chief Medical Officer | M Exercise | 2023-04-17 | 2023-04-19 | 44,861 | $0.37 | $16.6K | 253,278 | SEC↗ |
| Yeramian Patrick D | Chief Medical Officer | S Sale | 2023-04-17 | 2023-04-19 | 49,279 | $30.53 | $1.50M | 208,717 | SEC↗ |
| Yeramian Patrick D | Chief Medical Officer | S Sale | 2023-04-17 | 2023-04-19 | 300 | $30.94 | $9.3K | 208,417 | SEC↗ |
| Morningside Venture Investment | 10% Owner | S Sale | 2023-03-29 | 2023-03-31 | 29,048 | $30.45 | $884.5K | 6,997,302 | SEC↗ |
| Morningside Venture Investment | 10% Owner | S Sale | 2023-03-28 | 2023-03-29 | 100,000 | $30.37 | $3.04M | 7,026,350 | SEC↗ |
| Morningside Venture Investment | 10% Owner | S Sale | 2023-03-27 | 2023-03-29 | 28,000 | $30.80 | $862.4K | 7,126,350 | SEC↗ |
| Morningside Venture Investment | 10% Owner | S Sale | 2023-03-27 | 2023-03-29 | 32,964 | $30.25 | $997.2K | 7,154,350 | SEC↗ |
| Morningside Venture Investment | 10% Owner | S Sale | 2023-03-21 | 2023-03-23 | 34,641 | $31.69 | $1.10M | 7,216,121 | SEC↗ |
| Morningside Venture Investment | 10% Owner | S Sale | 2023-03-21 | 2023-03-23 | 28,807 | $32.17 | $926.7K | 7,187,314 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | A Award deriv | 2023-03-16 | 2023-03-20 | 97,500 | — | $0 | 97,500 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | A Award deriv | 2023-03-16 | 2023-03-20 | 225,000 | — | $0 | 225,000 | SEC↗ |
| Firestone Karen | Director | A Award deriv | 2023-03-16 | 2023-03-20 | 27,403 | — | $0 | 27,403 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | A Award deriv | 2023-03-16 | 2023-03-20 | 82,500 | — | $0 | 82,500 | SEC↗ |
| Yeramian Patrick D | Chief Medical Officer | A Award deriv | 2023-03-16 | 2023-03-20 | 41,250 | — | $0 | 41,250 | SEC↗ |
| Olinger Margaret | Chief Commercial Officer | A Award deriv | 2023-03-16 | 2023-03-20 | 82,500 | — | $0 | 82,500 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | A Award deriv | 2023-03-16 | 2023-03-20 | 225,000 | — | $0 | 225,000 | SEC↗ |
| Yeramian Patrick D | Chief Medical Officer | A Award deriv | 2023-03-16 | 2023-03-24 | 41,250 | — | $0 | 41,250 | SEC↗ |
| Yeramian Patrick D | Chief Medical Officer | M Exercise deriv | 2023-03-16 | 2023-03-24 | 2,789 | — | $0 | 0 | SEC↗ |
| Yeramian Patrick D | Chief Medical Officer | M Exercise deriv | 2023-03-16 | 2023-03-24 | 16,748 | — | $0 | 48,252 | SEC↗ |
| Yeramian Patrick D | Chief Medical Officer | M Exercise deriv | 2023-03-16 | 2023-03-24 | 30,041 | — | $0 | 62,466 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | A Award deriv | 2023-03-16 | 2023-03-24 | 97,500 | — | $0 | 97,500 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | M Exercise deriv | 2023-03-16 | 2023-03-24 | 32,500 | — | $0 | 414,500 | SEC↗ |
| Morningside Venture Investment | 10% Owner | S Sale | 2023-03-16 | 2023-03-17 | 9,122 | $32.55 | $296.9K | 7,250,762 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | A Award | 2023-03-16 | 2023-03-20 | 21,667 | — | $0 | 23,176 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | S Sale | 2023-03-16 | 2023-03-20 | 30,796 | $31.86 | $981.2K | 3,213 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | S Sale | 2023-03-16 | 2023-03-20 | 1,704 | $32.46 | $55.3K | 1,509 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | S Sale | 2023-03-16 | 2023-03-20 | 3,924 | $32.45 | $127.3K | 2,792,617 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | S Sale | 2023-03-16 | 2023-03-20 | 96,076 | $31.84 | $3.06M | 2,796,541 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | A Award | 2023-03-16 | 2023-03-20 | 50,000 | — | $0 | 2,842,617 | SEC↗ |
| Firestone Karen | Director | P Buy | 2023-03-16 | 2023-03-20 | 1,000 | $31.99 | $32.0K | 1,000 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | A Award | 2023-03-16 | 2023-03-20 | 18,333 | — | $0 | 55,747 | SEC↗ |
| Yeramian Patrick D | Chief Medical Officer | S Sale | 2023-03-16 | 2023-03-20 | 2,416 | $32.43 | $78.4K | 149,672 | SEC↗ |
| Yeramian Patrick D | Chief Medical Officer | S Sale | 2023-03-16 | 2023-03-20 | 52,211 | $31.85 | $1.66M | 152,088 | SEC↗ |
| Yeramian Patrick D | Chief Medical Officer | A Award | 2023-03-16 | 2023-03-20 | 9,167 | — | $0 | 158,839 | SEC↗ |
| MILNE GEORGE M JR | Director | S Sale | 2023-03-16 | 2023-03-20 | 1,916 | $32.45 | $62.2K | 862,021 | SEC↗ |
| MILNE GEORGE M JR | Director | S Sale | 2023-03-16 | 2023-03-20 | 33,084 | $31.86 | $1.05M | 863,937 | SEC↗ |
| Olinger Margaret | Chief Commercial Officer | A Award | 2023-03-16 | 2023-03-20 | 18,333 | — | $0 | 232,688 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | S Sale | 2023-03-16 | 2023-03-20 | 3,445 | $32.48 | $111.9K | 2,792,617 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | A Award | 2023-03-16 | 2023-03-20 | 50,000 | — | $0 | 2,842,617 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | S Sale | 2023-03-16 | 2023-03-20 | 96,555 | $31.84 | $3.07M | 2,796,062 | SEC↗ |
| Yeramian Patrick D | Chief Medical Officer | M Exercise | 2023-03-16 | 2023-03-24 | 30,041 | $0.37 | $11.1K | 237,129 | SEC↗ |
| Yeramian Patrick D | Chief Medical Officer | M Exercise | 2023-03-16 | 2023-03-24 | 16,748 | $6.88 | $115.2K | 253,877 | SEC↗ |
| Yeramian Patrick D | Chief Medical Officer | S Sale | 2023-03-16 | 2023-03-24 | 52,211 | $31.85 | $1.66M | 201,666 | SEC↗ |
| Yeramian Patrick D | Chief Medical Officer | M Exercise | 2023-03-16 | 2023-03-24 | 2,789 | $0.33 | $920 | 207,088 | SEC↗ |
| Yeramian Patrick D | Chief Medical Officer | S Sale | 2023-03-16 | 2023-03-24 | 2,416 | $32.43 | $78.4K | 199,250 | SEC↗ |
| Yeramian Patrick D | Chief Medical Officer | A Award | 2023-03-16 | 2023-03-24 | 9,167 | — | $0 | 208,417 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | M Exercise | 2023-03-16 | 2023-03-24 | 32,500 | $6.88 | $223.6K | 66,509 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | S Sale | 2023-03-16 | 2023-03-24 | 30,796 | $31.86 | $981.2K | 35,713 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | S Sale | 2023-03-16 | 2023-03-24 | 1,704 | $32.46 | $55.3K | 34,009 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | A Award | 2023-03-16 | 2023-03-24 | 21,667 | — | $0 | 55,676 | SEC↗ |
| Morningside Venture Investment | 10% Owner | S Sale | 2023-03-15 | 2023-03-16 | 108,934 | $33.12 | $3.61M | 7,300,950 | SEC↗ |
| Morningside Venture Investment | 10% Owner | S Sale | 2023-03-15 | 2023-03-16 | 41,066 | $33.68 | $1.38M | 7,259,884 | SEC↗ |
| Morningside Venture Investment | 10% Owner | S Sale | 2023-03-14 | 2023-03-16 | 70,714 | $34.54 | $2.44M | 7,409,884 | SEC↗ |
| Morningside Venture Investment | 10% Owner | S Sale | 2023-03-02 | 2023-03-06 | 50,000 | $33.75 | $1.69M | 7,480,598 | SEC↗ |
| Mazzariello Gina | Chief Legal Officer | S Sale | 2023-02-24 | 2023-02-28 | 3,586 | $34.49 | $123.7K | 37,414 | SEC↗ |
| Morningside Venture Investment | 10% Owner | S Sale | 2023-02-23 | 2023-02-24 | 1,111 | $36.24 | $40.3K | 7,580,598 | SEC↗ |
| Morningside Venture Investment | 10% Owner | S Sale | 2023-02-23 | 2023-02-24 | 48,889 | $35.55 | $1.74M | 7,581,709 | SEC↗ |
| Morningside Venture Investment | 10% Owner | S Sale | 2023-02-22 | 2023-02-24 | 39,916 | $35.91 | $1.43M | 7,640,682 | SEC↗ |
| Morningside Venture Investment | 10% Owner | S Sale | 2023-02-22 | 2023-02-24 | 10,084 | $36.34 | $366.5K | 7,630,598 | SEC↗ |
| Morningside Venture Investment | 10% Owner | S Sale | 2023-02-22 | 2023-02-28 | 47,888 | $34.70 | $1.66M | 7,532,710 | SEC↗ |
| Morningside Venture Investment | 10% Owner | S Sale | 2023-02-22 | 2023-02-28 | 2,112 | $35.34 | $74.6K | 7,530,598 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | S Sale | 2023-01-06 | 2023-01-10 | 4,122 | $36.08 | $148.7K | 2,894,463 | SEC↗ |
| Klee Justin B. | Co-Chief Executive Officer | S Sale | 2023-01-06 | 2023-01-10 | 1,846 | $36.79 | $67.9K | 2,892,617 | SEC↗ |
| Olinger Margaret | Chief Commercial Officer | S Sale | 2023-01-06 | 2023-01-10 | 743 | $36.79 | $27.3K | 214,355 | SEC↗ |
| Olinger Margaret | Chief Commercial Officer | S Sale | 2023-01-06 | 2023-01-10 | 1,660 | $36.08 | $59.9K | 215,098 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | S Sale | 2023-01-06 | 2023-01-10 | 1,836 | $36.08 | $66.2K | 34,831 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | S Sale | 2023-01-06 | 2023-01-10 | 822 | $36.79 | $30.2K | 34,009 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | S Sale | 2023-01-06 | 2023-01-10 | 1,846 | $36.79 | $67.9K | 2,892,617 | SEC↗ |
| Cohen Joshua B | Co-Chief Executive Officer | S Sale | 2023-01-06 | 2023-01-10 | 4,122 | $36.08 | $148.7K | 2,894,463 | SEC↗ |
| Yeramian Patrick D | Chief Medical Officer | S Sale | 2023-01-06 | 2023-01-10 | 1,405 | $36.08 | $50.7K | 204,928 | SEC↗ |
| Yeramian Patrick D | Chief Medical Officer | S Sale | 2023-01-06 | 2023-01-10 | 629 | $36.79 | $23.1K | 204,299 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | M Exercise deriv | 2022-12-30 | 2023-01-04 | 5,000 | — | $0 | 447,000 | SEC↗ |
| FRATES JAMES M | Chief Financial Officer | M Exercise | 2022-12-30 | 2023-01-04 | 5,000 | $6.88 | $34.4K | 36,667 | SEC↗ |
| Viking Global Opportunities Il | 10% Owner | C Conversion deriv | 2022-11-11 | 2022-01-13 | 4,870,536 | — | $0 | 0 | SEC↗ |
| Viking Global Opportunities Il | 10% Owner | S Sale | 2022-09-09 | 2022-09-09 | 3,142 | $31.44 | $98.8K | 1,850,940 | SEC↗ |
| Viking Global Opportunities Il | 10% Owner | S Sale | 2022-09-09 | 2022-09-09 | 73,886 | $30.90 | $2.28M | 1,854,082 | SEC↗ |
| Viking Global Opportunities Il | 10% Owner | S Sale | 2022-09-09 | 2022-09-09 | 147,502 | $29.87 | $4.41M | 1,927,968 | SEC↗ |
| Viking Global Opportunities Il | 10% Owner | S Sale | 2022-09-09 | 2022-09-09 | 6,654 | $31.44 | $209.2K | 3,919,596 | SEC↗ |
| Viking Global Opportunities Il | 10% Owner | S Sale | 2022-09-09 | 2022-09-09 | 156,463 | $30.90 | $4.83M | 3,926,250 | SEC↗ |
| Viking Global Opportunities Il | 10% Owner | S Sale | 2022-09-09 | 2022-09-09 | 312,353 | $29.87 | $9.33M | 4,082,713 | SEC↗ |
| Viking Global Opportunities Il | 10% Owner | S Sale | 2022-09-08 | 2022-09-09 | 108,631 | $28.16 | $3.06M | 4,681,190 | SEC↗ |
| Viking Global Opportunities Il | 10% Owner | S Sale | 2022-09-08 | 2022-09-09 | 80,715 | $27.28 | $2.20M | 4,789,821 | SEC↗ |
| Viking Global Opportunities Il | 10% Owner | S Sale | 2022-09-08 | 2022-09-09 | 159,026 | $29.14 | $4.63M | 4,522,164 | SEC↗ |
| Viking Global Opportunities Il | 10% Owner | S Sale | 2022-09-08 | 2022-09-09 | 52,466 | $32.23 | $1.69M | 2,075,470 | SEC↗ |
| Viking Global Opportunities Il | 10% Owner | S Sale | 2022-09-08 | 2022-09-09 | 7,554 | $30.59 | $231.1K | 2,127,936 | SEC↗ |
| Viking Global Opportunities Il | 10% Owner | S Sale | 2022-09-08 | 2022-09-09 | 75,096 | $29.14 | $2.19M | 2,135,490 | SEC↗ |